Immunization of Mice with a Recombinant Adenovirus Vaccine Inhibits the Early Growth of Mycobacterium tuberculosis After Infection

Immunization of Mice with a Recombinant Adenovirus Vaccine Inhibits the Early Growth of Mycobacterium tuberculosis After Infection

Show other versions (1)

Bibliographic Details
Main Authors:	Ronan, E, Lee, L, Beverley, P, Tchilian, E
Format:	Journal article
Published:	2009

Similar Items

Immunization of mice with a recombinant adenovirus vaccine inhibits the early growth of Mycobacterium tuberculosis after infection.
by: Ronan, E, et al.
Published: (2009)

Immunization of mice with a recombinant adenovirus vaccine inhibits the early growth of Mycobacterium tuberculosis after infection.
by: Edward O Ronan, et al.
Published: (2009-12-01)

Nasal associated lymphoid tissue (NALT) contributes little to protection against aerosol challenge with Mycobacterium tuberculosis after immunisation with a recombinant adenoviral vaccine.
by: Ronan, E, et al.
Published: (2010)

Nasal associated lymphoid tissue (NALT) contributes little to protection against aerosol challenge with Mycobacterium tuberculosis after immunisation with a recombinant adenoviral vaccine.
by: Ronan, E, et al.
Published: (2010)

Chemokine gene expression in lung CD8 T cells correlates with protective immunity in mice immunized intra-nasally with Adenovirus-85A.
by: Lee, L, et al.
Published: (2010)

Environmental effects on protection against Mycobacterium tuberculosis after immunization with Ad85A.
by: Beverley, P, et al.
Published: (2013)

Understanding vaccine induced protective immunity to Mycobacterium tuberculosis
by: Ronan, E
Published: (2011)

Harnessing local and systemic immunity for vaccines against tuberculosis.
by: Beverley, P, et al.
Published: (2014)

CXCR6 is a marker for protective antigen-specific cells in the lungs after intranasal immunization against Mycobacterium tuberculosis.
by: Lee, L, et al.
Published: (2011)

CXCR6 Is a Marker for Protective Antigen-Specific Cells in the Lungs after Intranasal Immunization against Mycobacterium tuberculosis
by: Lee, L, et al.
Published: (2011)

Immunization with different formulations of Mycobacterium tuberculosis antigen 85A induces immune responses with different specificity and protective efficacy
by: Tchilian, E, et al.
Published: (2013)

Immunization with different formulations of Mycobacterium tuberculosis antigen 85A induces immune responses with different specificity and protective efficacy
by: Tchilian, E, et al.
Published: (2013)

Immunization with different formulations of Mycobacterium tuberculosis antigen 85A induces immune responses with different specificity and protective efficacy.
by: Tchilian, E, et al.
Published: (2013)

Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice.
by: Forbes, E, et al.
Published: (2008)

Lessons for tuberculosis vaccines from respiratory virus infection.
by: Beverley, P, et al.
Published: (2008)

Lessons for tuberculosis vaccines from respiratory virus infection
by: Beverley, P, et al.
Published: (2008)

Simultaneous immunization against tuberculosis.
by: Tchilian, E, et al.
Published: (2011)

Simultaneous immunization against tuberculosis.
by: Tchilian, E, et al.
Published: (2011)

Recombinant BCG vaccine expressing multistage antigens of Mycobacterium tuberculosis provides long-term immunity against tuberculosis in BALB/c mice
by: Danang Fang, et al.
Published: (2024-12-01)

A novel murine cytomegalovirus vaccine vector protects against Mycobacterium tuberculosis.
by: Beverley, P, et al.
Published: (2014)

Dose Effects of Recombinant Adenovirus Immunization in Rodents
by: Eric A. Weaver
Published: (2019-10-01)

Protection Induced by Simultaneous Subcutaneous and Endobronchial Vaccination with BCG/BCG and BCG/Adenovirus Expressing Antigen 85A against Mycobacterium bovis in Cattle.
by: Gillian S Dean, et al.
Published: (2015-01-01)

Mycobacterium tuberculosis infection interferes with HIV vaccination in mice.
by: Lech Ignatowicz, et al.
Published: (2012-01-01)

Cold-adapted influenza and recombinant adenovirus vaccines induce cross-protective immunity against pH1N1 challenge in mice.
by: Mark R Soboleski, et al.
Published: (2011-01-01)

Adenovirus Biology, Recombinant Adenovirus, and Adenovirus Usage in Gene Therapy
by: Maki Watanabe, et al.
Published: (2021-12-01)

Immunogenicity in Mice Immunized with Recombinant Adenoviruses Expressing Varicella-Zoster Virus Envelope Glycoprotein E
by: Yanpeng Zheng, et al.
Published: (2023-11-01)

Mixed vector immunization with recombinant adenovirus and MVA can improve vaccine efficacy while decreasing antivector immunity
by: Reyes-Sandoval, A, et al.
Published: (2012)

Mixed vector immunization with recombinant adenovirus and MVA can improve vaccine efficacy while decreasing antivector immunity.
by: Reyes-Sandoval, A, et al.
Published: (2012)

Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice.
by: Maria A Croyle, et al.
Published: (2008-01-01)

Construction and Evaluation of Recombinant Adenovirus Candidate Vaccines for Chikungunya Virus
by: Liang Cao, et al.
Published: (2022-08-01)

Characterization of recombinant gorilla adenovirus HPV therapeutic vaccine PRGN-2009
by: Samuel T. Pellom, et al.
Published: (2021-04-01)

Innate Immune Responses to Chimpanzee Adenovirus Vector 155 Vaccination in Mice and Monkeys
by: Catherine Collignon, et al.
Published: (2020-11-01)

Cellular immune responses to nine Mycobacterium tuberculosis vaccine candidates following intranasal vaccination.
by: Suraj B Sable, et al.
Published: (2011-01-01)

Rapid functional exhaustion and deletion of cytotoxic T lymphocytes following immunization with recombinant adenovirus
by: Krebs P, et al.
Published: (2004-07-01)

Evaluation of the humoral immune response and cross reactivity against <it>Mycobacterium tuberculosis</it> of mice immunized with liposomes containing glycolipids of <it>Mycobacterium smegmatis</it>
by: Borrero Reinier, et al.
Published: (2013-02-01)

Immunotherapeutic effects of Mycobacterium tuberculosis rv3407 DNA vaccine in mice
by: Yan Liang, et al.
Published: (2018-11-01)

Phosphodiesterase 4 inhibition reduces innate immunity and improves isoniazid clearance of Mycobacterium tuberculosis in the lungs of infected mice.
by: Mi-Sun Koo, et al.
Published: (2011-02-01)

Vaccination with recombinant Mycobacterium tuberculosis PknD attenuates bacterial dissemination to the brain in guinea pigs.
by: Ciaran Skerry, et al.
Published: (2013-01-01)

Immunogenicity and protective efficacy of prime-boost regimens with recombinant (delta)ureC hly+ Mycobacterium bovis BCG and modified vaccinia virus ankara expressing M. tuberculosis antigen 85A against murine tuberculosis.
by: Tchilian, E, et al.
Published: (2009)

Vaccine-induced immunity circumvented by typical Mycobacterium tuberculosis Beijing strains.
by: Kremer, K, et al.
Published: (2009)